-
Most Popular
Healthcare Stocks
Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.
7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024
These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.
7 Dependable Dividend Stocks for Long-Term Income
Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.
3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct
These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.
Other industries you might be interested in
Recent Healthcare Stocks Articles
Recent Aurora Stock News Leaves Investors Wondering: Buy, Hold or Sell?
After the recent quarterly report and the general outlook, it is not prudent to recommend Aurora stock as a buy. Covered calls or put spreads present an alternative to play ACB.
The Top Performing Sector in 2020 Will Be …
The future of healthcare will really start to take shape this year, and the next decade will bring advancements that we can only imagine in our wildest dreams.
Healthcare AI: 2 Transformative Technologies Can Make You Rich
The integration of AI will drive the future of healthcare. The train is taking off, but it’s not too late to climb on board.
Cannabis Stocks Are Flirting With a Bottom
Canopy Growth is leading the way toward a bottom in cannabis stocks after reporting better-than-expected revenue growth on Valentine's Day.
2020 Could Be the Year Cronos Comes Alive
Cronos Group reports its fourth-quarter and full-year results on Feb. 27. Owners of CRON stock shouldn’t expect much in the near term.
30 Marijuana Stocks to Buy as the Future Turns Green
Thanks to favorable public sentiment and political tailwinds, the list of marijuana stocks to buy is both extensive and diverse.
Earnings Preview: Analysts Expect Canopy Growth’s Revenue to Slump
CGC stock is likely to languish after its fiscal third-quarter earnings report unless it can prove it's on track to be profitable soon.
OrganiGram Stock is a Reasonable Cannabis Bet Amid a Sea of Riskier Ones
OrganiGram stock skyrocketed off its fiscal Q1 earnings report but just as quickly came tumbling back down. However, the underlying company is better positioned than most to enjoy a solid year in 2020.
Canopy Growth Stock Remains a Long-Term Buy Ahead of Earnings
CGC stock has faded again into earnings, and cannabis stocks could see volatility ahead. But any dip is a long-term buying opportunity.
Canopy Growth Needs to Keep Cash High in Order to Survive
New CEO David Klein needs to limit his cash burn and save struggling Cannabis 2.0 investments in order for CGC stock to survive.
2020 Now Looks Even Uglier for Aurora Cannabis Stock
Aurora stock needs to show investors the money soon. And this week's earnings report isn't likely to bring much money, or hope.
Stick with the Recent Rally in Canopy Growth Stock
After plunging in 2019, CGC stock could rebound in a big way in 2020 thanks to three major growth catalysts.
Aurora Cannabis Stock Is Losing Cash and Liquidity Options
Aurora Cannabis is running out of cash and liquidity options-- and will likely have to raise equity that will further dilute Aurora stock.
Investors Should Forget Aurora Cannabis and Buy GWPH Stock Instead
Demand for legal cannabis is not as strong as bulls predicted. As a result, investors should avoid big names like Aurora stock.
4 Things Investors Must Consider Before Buying Aurora Cannabis
Aurora stock is currently one of the worst-performing Canadian cannabis companies. Here are a few things to know before investing.
Organigram Stock a Standout Long-Term Winner in the Cannabis Sector
With plenty of demand and legalization efforts, the long-term growth story is still very much intact with Organigram stock.
